SEC Form 4
FORM 4

[  ] Check this box if no longer
subject to Section 16. Form 4 or Form
5 obligations may continue.
See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility
Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL



OMB Number: 3235-0287
Expires: January 31, 2005
Estimated average burden
hours per response. . . . . 0.5
1. Name and Address of Reporting Person*
Hiatt, Robert L.

(Last)                      (First)                      (Middle)
980 North Michigan Avenue
Suite 1620

(Street)
Chicago,    IL   60611

(City)                      (State)                      (Zip)

2. Issuer Name
and Ticker or Trading Symbol

NovaMed Eyecare, Inc.
NOVA

3. I.R.S. Identification
    Number of Reporting
    Person, if an entity
    (voluntary)
4. Statement for
    (Month/Day/Year

03/21/2003


5. If Amendment,
    Date of Original
    (Month/Day/Year)

6. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

   Director      10% Owner
X Officer (give title below)        Other (specify below)

Description           Vice President Finance

7. Individual or Joint/Group
    Filing (Check Applicable Line)

X   Form filed by One Reporting Person
     Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security
    (Instr. 3)

2.Transaction
Date
(Month/Day/Year)
2A. Deemed Execution Date, if any
(Month/Day/Year)
3. Transaction
    Code
    (Instr. 8)
4. Securities Acquired (A) or Disposed Of (D)
    (Instr. 3, 4, and 5)
5. Amount of
    Securities
    Beneficially
    Owned Following
    Reported Transaction(s)

    (Instr. 3 and 4)
6. Owner-
    ship
    Form:
    Direct (D)
    or
    Indirect (I)

    (Instr. 4)
7. Nature of
     Indirect
     Beneficial
     Ownership

    (Instr. 4)
Code
V
Amount
A/D
Price
Common Stock
$
5,238
D


Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
    (Instr. 3)
2. Conver-
    sion or
    Exercise
    Price of
    Deri-
    vative
    Security
3. Transaction Date

(Month/
Day/
Year)
3A. Deemed Execution Date, if any

(Month/
Day/
Year)
4. Transaction Code
    (Instr.8)
5. Number of Derivative
    Securities Acquired (A)
    or Disposed Of (D)

    (Instr. 3, 4 and 5)
6. Date Exercisable(DE) and
    Expiration Date(ED)
    (Month/Day/Year)
7. Title and Amount of
    Underlying Securities
    (Instr. 3 and 4)
8. Price
    of
    Derivative
    Security
    (Instr.5)
9. Number of
    Derivative
    Securities
    Beneficially
    Owned
    Following
    Reported
    Transaction(s)
    (Instr.4)
10. Owner-
ship
Form of
Deriv-
ative
Securities:
Direct (D)
or
Indirect (I)

(Instr.4)
11. Nature of
      Indirect
      Beneficial
      Ownership
      (Instr.4)
Code
V
A
D
DE
ED
Title
Amount or Number of Shares
Stock Option (right to buy) $2.40 09/22/1997
A
10,000       
(1)
09/22/2007
Common Stock
10,000
$
D
Stock Option (right to buy) $12.00 03/09/2000
A
3,000       
(2)
03/09/2010
Common Stock
3,000
$
D
Stock Option (right to buy) $1.0625 12/29/2000
A
30,000       
(3)
12/29/2010
Common Stock
30,000
$
D
Stock Option (right to buy) $1.75 04/20/2001
A
30,000       
(4)
04/20/2011
Common Stock
30,000
$
D
Stock Option (right to buy) $0.78 04/02/2002
A
40,000       
(5)
04/02/2012
Common Stock
40,000
$
D
Stock Option (right to buy) $1.27 03/21/2003
A
15,000       
(6)
03/21/2013
Common Stock
15,000
$
D

Explanation of Responses:

 
(1) This option was originally granted for 20,000 shares on September 22, 1997. Subject to certain restrictions, 2,500 of these options vested on March 21, 1998, with the remainder vesting 216 per month starting on April 21, 1998. The Reporting Person exercised and sold 10,000 shares in February 2000. This exercise and sale occurred prior to this individual becoming a Reporting Person.
(2) Subject to certain restrictions, 375 of these options vested on September 8, 2000, with the remainder vesting 62 per month starting on October 8, 2000.
(3) Subject to certain restrictions, 3,750 of these options vested on June 28, 2001, with the remainder vesting 625 per month starting on July 28, 2001.
(4) Subject to certain restrictions, 3,750 of these options vested on October 19, 2001, with the remainder vesting 625 per month starting on November 19, 2001.
(5) Subject to certain restrictions, 5,000 of the options vested on October 1, 2002, with the remainder vesting 833 per month starting on November 2, 2002.
(6) Subject to certain restrictions, 1,875 of these options will vest on September 20, 2003, with the remainder vesting 312 per month starting on October 21, 2003.
By: Date:
/s/ ROBERT L. HIATT 03/25/2003
ROBERT L. HIATT
** Signature of Reporting Person
SEC 1474 (9-02)


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Potential persons who are to respond to the collection of information contained in this form are not
required to respond unless the form displays a currently valid OMB Number.